| 摘要 |
The invention provides a novel crystalline anhydride of tiotropium bromide, a method for producing said anhydride and the use thereof for producing a medicament for the treatment of respiratory tract diseases, in particular, for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. |
